Zhenghai Biotech (300653.SZ) announced 2024 annual results, with net profit of 135 million yuan to mother, a decrease of 29.49%

Zhitongcaijing · 4d ago

According to the Zhitong Finance App, Zhenghai Biotech (300653.SZ) released its 2024 annual report. The company's revenue was 363 million yuan, a decrease of 12.19% over the previous year. Net profit attributable to shareholders of listed companies was 135 million yuan, a year-on-year decrease of 29.49%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was $113 million, a year-on-year decrease of 32.59%. Basic earnings per share were $0.75. In addition, it is proposed to distribute a cash dividend of 4.60 yuan (tax included) for every 10 shares to all shareholders.